Toxic clozapine serum levels during acute urinary tract infection: A case report

European Journal of Clinical Pharmacology

Volumn 60, Issue 12, 2005, Pages 909-910

  Jecel, Julia ^a   Michel, Tanja M ^a   Gutknecht, Lise ^a   Schmidt, Daniela ^a   Pfuhlmann, Bruno ^a   Jabs, Burkhard E ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; ANTIDEPRESSANT AGENT; CLOZAPINE; COTRIMOXAZOLE; MIRTAZAPINE; NEUROLEPTIC AGENT; NORCLOZAPINE; PARACETAMOL;

ACUTE DISEASE; ADULT; AKINESIA; ANAMNESIS; ANTIBIOTIC THERAPY; APHASIA; ARTICLE; BLOOD SAMPLING; CASE REPORT; CLINICAL FEATURE; DRUG DOSE REDUCTION; DRUG INTOXICATION; ESCHERICHIA COLI; FEMALE; FEVER; GAIT DISORDER; HOSPITALIZATION; HUMAN; LABORATORY TEST; MAINTENANCE DRUG DOSE; MAINTENANCE THERAPY; MANIC PSYCHOSIS; PARANOID PSYCHOSIS; PRIORITY JOURNAL; SINGLE DRUG DOSE; SPEECH DISORDER; URINARY TRACT INFECTION;

ACUTE DISEASE; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; CLOZAPINE; FEMALE; HUMANS; MIDDLE AGED; URINARY TRACT INFECTIONS;

EID: 15244362996     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-004-0867-4     Document Type: Article

References (11)

1. Pirmohamed M, Williams D, Madden S, Templeton E, Park BK (1995) Metabolism and bioactivation of clozapine by human liver in vitro. J Pharmacol Exp Ther 272:984-990
2. Prior TI, Baker GB (2003) Interactions between the cytochrome P450 system and the second-generation antipsychotics. J Psychiatry Neurosci 28:99-112
3. Raaska K, Raitasuo V, Arstila M, Neuvonen PJ (2002) Bacterial pneumonia can increase serum concentration of clozapine. Eur J Clin Pharmacol 58:321-322
4. Renton KW (2000) Hepatic drug metabolism and immunostimulation. Toxicology 142:173-178
5. Wetzel H, Anghelescu I, Szegedi A, Wiesner J, Weigmann H, Harter S, Hiemke C (1998) Pharmacokinetic interactions of clozapine with selective serotonin reuptake inhibitors: differential effects of fluvoxamine and paroxetine in a prospective study. J Clin Psychopharmacol 18:2-9
6. Raaska K, Neuvonen PJ (2000) Ciprofloxacin increases serum clozapine and N-desmethylclozapine: a study in patients with schizophrenia. Eur J Clin Pharmacol 56:585-589
7. Jeppessen U, Gram LF, Vistisen K, Loft S, Poulsen HE, Brøsen K (1996) Dose-dependent inhibition of CYP1A2, CYP2C19 and CYPD6 by citalopram, fluoxetine, fluvoxamine and paroxetine. Eur J Clin Pharmacol 51:73-78
8. Batty KY, Davis TM, Ilett KF, Dusci LJ, Langton SR (1995) The effect of ciprofloxacin on theophylline pharmacokinetics in healthy subjects. Br J Clin Pharmacol 39:305-311
9. Olesen OV, Linnet K (2000) Fluvoxamine-clozapine drug interaction inhibition in vitro of five cytochrome P450 isoforms involved in clozapine metabolism. J Clin Psychopharmacol 20:35-42
10. Anttila SA, Leinonen EV (2001) A review of the pharmacological and clinical profile of mirtazapine. CNS Drug Rev 7:249-264
11. Spina E, Scordo MG, D'Arrigo C (2003) Metabolic drug interactions with new psychotropic agents. Fundam Clin Pharmacol 17:517-538